Navigation Links
Rolling in Biological Technology

Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results

... for the completion of its ONCONASE(R) rolling New Drug Application (NDA) submission. Decreased ... to complete the final sections of the ONCONASE rolling NDA. As the company has previously reported, the ... to estimate that the final components of the rolling NDA will be submitted by the end of 2008, and the ...

Alfacell Reports Financial Results for Third Quarter of Fiscal 2008

... for the completion of its ONCONASE(R) rolling New Drug Application ("NDA") submission. ... to complete the final sections of the ONCONASE rolling NDA. As the company has previously reported, the ... "We are moving forward with the completion of our rolling NDA and appreciate the support expressed by our ...

Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim

... Arpida Ltd. (SWX: ARPN) today reported that the rolling submission of the New Drug Application (NDA) for ... Drug Administration (FDA) to file the NDA in a rolling process. Using a 'rolling NDA' allows ... to file the NDA in an electronic format. Both the rolling NDA and the electronic format could potentially ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... FDA and the agency has approved Fast Track designation for the product. rolling review of the New Drug Application ("NDA") has started. Our core ... for the treatment of Gaucher disease. On July 30 Shire began the rolling submission of a NDA for velaglucerase alfa to treat patients with ...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

... events. Data from this trial will be incorporated into picoplatin's rolling New Drug Application (NDA) filing, which the Company plans to initiate by ... at a major medical meeting; Initiate submission of a rolling NDA with the FDA for picoplatin as a second-line treatment for SCLC in ...

Cell Therapeutics Targeting Potential Zevalin Label Expansion, Pixantrone and OPAXIO Drug Approvals to Grow Commercial Operations and Revenues in 2009

... and, based on positive Phase III data for pixantrone, we expect to file a rolling NDA in 2009. Additionally, we continue to focus on improving our capital ... FDA meeting later this quarter, CTI currently plans to submit a rolling NDA filing for pixantrone with potential Q4- 2009 approval and launch in ....

Full Sail University Welcomed Back to Campus Graduate and Acclaimed Horror Director, Darren Lynn Bousman

... Gaming Monthly; one of the Best Music Programs in the country by rolling Stone Magazine; one of the Best Music Business Departments in the Schools That Rock: The rolling Stone College Guide; and one of the Best Film Programs in the country by ...

Alfacell Hires Advisors to Advance Strategic Alternatives

... president. "We continue to make progress on the completion of our rolling new drug application (NDA) and have undertaken this project in an effort ... mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical ...

Arpida Announces Full Year 2007 Financial Results

... has further agreed to file the NDA in an electronic format. Both the rolling NDA and the electronic format could greatly facilitate the review process. The rolling submission of the NDA package got underway in 2007 and is expected to be ...

Winter Park Home to World's Foremost Producers of Large-Scale Decontamination Equipment

... decontamination of both the interior and exterior of large assets such as airplanes, ambulances, emergency vehicles, police cars and hospital rolling stock, such as stretchers and wheel chairs, in less than two hours. Not only can AeroClave's system save billions of dollars in stopping the ...

UCR scientists manipulate ripples in graphene, enabling strain-based graphene electronics

... structure is a two-dimensional honeycomb lattice of carbon atoms. Structurally, it is related to carbon nanotubes (tiny hollow tubes formed by rolling up sheets of graphene) and buckyballs (hollow carbon molecules that form a closed cage). ...

MedNet Solutions to Introduce New EDC/eClinical Technologies at the 2009 Drug Information Association Annual Meeting

... quality, while reducing overall timelines and costs," stated Kevin Anderson, Vice President of Marketing at MedNet Solutions. "We're thrilled to be rolling out these innovative new features at DIA, where representatives from leading sponsor and CRO organizations will be able to see firsthand how MedNet ...

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

... and tachycardia. The ASCO poster is available at http://www.celltherapeutics.com/investor_updates . In April 2009, CTI began a rolling submission of a New Drug Application ("NDA") with the U.S. Food and Drug Administration (the "FDA") for pixantrone to treat relapsed or refractory ...

Roche Announces Back-to-Basics Approach to Diabetes Care - Simpler is Better

... glucose levels, giving them greater control in their everyday battles against diabetes. As the world leader in diabetes diagnostics, Roche is rolling out the ACCU-CHEK Testing in Pairs and ACCU-CHEK 360-degree View tools as a way to help adults, children and teens manage their diabetes more easily ...

Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial

... American Society of Clinical Oncology Annual Meeting to be held from May 29 to June 2, 2009 in Orlando, Florida. In April 2009, CTI began a rolling submission of a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for pixantrone to treat relapsed or refractory aggressive ...

Sixth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Chronic Care Management & Wellness Promotion

... rolling HILLS ESTATES, Calif., May 7 /PRNewswire/ -- The Sixth Annual Healthcare Unbound Conference & Exhibition, organized by The Center for Business ...

GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2

... built into the software means that entire networks of end-users can be administered from a centralized location. With this release, we are also rolling out a simple yet scalable licensing model that enables our customers to start small, with the option to scale-up and add more users as they derive ...

DuPont Leader: Agriculture is Up to Global Productivity Challenge

... in agricultural productivity have been achieved by inventing and adopting new technologies and management practices in North America and Europe, then rolling them out to other countries," he said. "Progress has been made with this approach, but we must leverage science-based knowledge and ...

Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview

... store blood specimens for research and treatment of diseases. "We are the shipping container, we are the foundation, we're the driveway. We're not rolling the dice on getting FDA approval on some therapy that may take ten years to develop," said Koos in the TWST news interview. "We plan to fill a key ...

NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results

... 2008 was the second year in a row that we were able to grow our revenues by approximately 75% and we accomplished much during the year, including rolling out many new products, growing our sales force considerably and achieving near break-even in our cash flow from operations. Although our fourth ...

ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability

... Integrated Roll-up for Increased Accuracy and Speed - The software eliminates errors in the time-consuming re-keying involved with manually rolling up multiple study plans into program- or company-wide forecasts. ClearTrial Portfolio Planning also ensures that planners are using the most current ...

Alfacell Provides ONCONASE(R) NDA Submission Update

... pre-NDA meeting with the U.S. Food and Drug Administration (FDA) to discuss the company's planned submission of the final components of the ONCONASE rolling New Drug Application (NDA) for the treatment of unresectable malignant mesothelioma (UMM) patients. At the pre-NDA meeting, the FDA provided ...

EAU Technologies Receives Patent for Empowered Water(TM)

... application. Following that, we protect it as best as we can while we develop a realistic business model and find an industry partner to assist with rolling out the technology," said Wade Bradley, CEO of EAU Technologies, Inc. "Mold remediation proved very effective early on. As mold is a major cause of ...

Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products

... 9. Sleep disorders. President & CEO, Richard Cowan, states, "We are certainly pleased at the speed in which our business model is rolling out. The potential market size for some of these products is obviously very large. When multiplied by the various categories and compounded by ...

Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA

... completed Phase III clinical trials of ONCONASE in unresectable malignant mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit ...

China-Biotics, Inc. Reports First Quarter 2009 Financial Results

... said. ''We are pleased that we were able to begin achieving meaningful sales of our bulk additives to commercial customers. We are also working on rolling out new retail outlets as quickly as we can. Those outlets already open more than one year have demonstrated tremendous year-over-year sales growth, ...

Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results

... globally with net sales reaching $168.5 million in the second quarter, indicating expanding global demand for the brand. Based on a series of rolling launches worldwide, we expect to see additional growth opportunities for Nexavar, particularly for the treatment of liver cancer," said Tony Coles, ....

A first in integrated nanowire sensor circuitry

... The Javey group has devised two printing methods, contact and roller. The roller method involves growing nanowires on the surface of a cylinder and rolling it across the application substrate, like painting with a paint roller. Contact printing involves growing nanowires on a flat substrate, ...

Alfacell Receives NASDAQ Delisting Letter

... completed Phase III clinical trials of ONCONASE in unresectable malignant mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit ...

eFuture Signs Contract to Provide Tiens Group with Retail Business Management System

... 100 direct- sales stores and 1,000 franchised chain stores, which have a total customer base of over 10 million. ''We are excited to be rolling out one of our high-performance software solutions to support Tiens Group's wide-ranging global operations," said Mr. Adam Yan, eFuture's chairman ...

Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing

... million shares and warrants issued in conjunction with the private financing and just under two million incentive options available under a 10% rolling plan. None of the above securities have been or are expected to be registered under the United States Securities Act of 1933 and may not be offered ...

Alfacell Receives NASDAQ Non-Compliance Notification

... completed Phase III clinical trials of ONCONASE in unresectable malignant mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit ...

Fifth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Disease Management & Wellness Promotion

... rolling HILLS ESTATES, Calif., June 19 /PRNewswire-USNewswire/ -- The Fifth Annual Healthcare Unbound Conference and Exhibition, hosted by The Center for ...

Elsevier's Engineering Village Search Platform Combines the American Geological Institute's Georef Database With Google Maps

... in their fields. Using Google Maps, search results from these two databases can be easily navigated by zooming in, zooming out, moving around, or rolling over an icon to find out which location it represents and how many records are associated with that location. Specifically, the mapping function ...

Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance

... often and to involve all the major stakeholders in the process," said Mike Herrick, program manager and project leader at CSI. "We look forward to rolling this out and talking to other states about how to implement it and improve the health and safety of their citizens." About Collaborative Software ...

Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service

... INDIANAPOLIS, May 14 /PRNewswire-FirstCall/ -- Thousands of Eli Lilly and Company employees in nearly 50 nations are rolling up their sleeves today to help address local community needs in celebration of Lilly's first-ever Global Day of Service, possibly the largest ...

Genzyme Provides Update on Myozyme(R) Manufacturing

... a separate biologics license application (BLA) to gain approval for Myozyme produced at the 2000L scale. The agency proposed that Genzyme initiate a rolling BLA review process by submitting results from the LOTS study. Genzyme expects the FDA to give the BLA priority review and to act on the application ...

New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management

... Halogen eAppraisal and Multi-Rater based on the flexibility of the solution, as it could be configured without IT or vendor involvement. Since rolling out the solution, under the leadership of partner Kathy Anthony, the firm has realized a number of benefits including productivity gains, improved ...

NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007

... our days sales outstanding ("DSO") at December 31, 2007 was approximately 78 days, down from 81 days on September 30, 2007. By the end of January our rolling three months DSO had fallen to 71 days. As a result, we turned cash flow from operations positive in January and we should be cash flow from ...

Alfacell Reports Financial Results for Second Quarter of Fiscal 2008

... recent fiscal quarter," said Kuslima Shogen, Alfacell's chief executive officer. "We have made considerable progress towards the completion of our rolling NDA and we have entered into key partnerships to promote and prepare for the successful commercialization of ONCONASE(R)." Clinical Trials Update ...
Other Contents
(Date:7/28/2014)... found that 73 percent of adult survivors of childhood ... syndrome and related health problems by failing to follow ... issue of the journal Cancer . , Almost ... cancer in the study had metabolic syndrome, an umbrella ... abdominal obesity, elevated triglyceride and other abnormalities that often ...
(Date:7/28/2014)... CITY (July 28, 2014)The Brain & Behavior Research ... Klerman and Freedman Prizes, recognizing exceptional clinical and ... supported by NARSAD Young Investigator Grants. The grants ... in neurobiological and psychosocial research for the prevention, ... that affect one in four people. , Six ...
(Date:7/28/2014)... , July 28, 2014 Research and ... "Biometrics Market in Latin America 2014-2018" report to ... Biometrics measure and analyze biological data. These ... irises, eye retinas, voice patterns, and hand measurements from ... more stored templates. The main purpose of a biometrics ...
Breaking Biology News(10 mins):Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Biometrics Market in Latin America 2014-2018 2
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 ... recipe app for iOS, App is available on iTunes for ... first of its kind, Audio Chef allows you to listen ... gourmet cuisine the easy way: simply get out the ingredients ... no need to measure or prepare ingredients ahead of time, ...
(Date:7/28/2014)... meal you,ve ordered at a restaurantor when something ... your brain. , These waves are called ... cellsboth excitatory and inhibitoryplaying together in an orchestrated ... waves have been associated with higher-level brain function, ... to schizophrenia, Alzheimer,s disease, autism, epilepsy and other ...
(Date:7/28/2014)... 28, 2014 UT Southwestern Medical Center cancer ... irreversibly interferes with the activity of a mutated ... , The molecule, SML-8-73-1 (SML), interferes with the ... homolog. The gene produces proteins called K-Ras that ... result in normal cells dividing uncontrollably and turning ...
(Date:7/28/2014)... 2014 The report, “Blowing Agents ... - Trends and Forecasts to 2019” defines and ... and forecasting of the global consumption volume and ... tables with 39 figures spread through 226 Pages ... http://www.marketsandmarkets.com/Market-Reports/blowing-agents-market-71329121.html , Blowing agents are highly utilized ...
Breaking Medicine News(10 mins):Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4
Other TagsOther Tags